239 related articles for article (PubMed ID: 29936631)
1. Increased plasma xanthine oxidoreductase activity deteriorates coronary artery spasm.
Watanabe K; Shishido T; Otaki Y; Watanabe T; Sugai T; Toshima T; Takahashi T; Yokoyama M; Kinoshita D; Murase T; Nakamura T; Wanezaki M; Tamura H; Nishiyama S; Takahashi H; Arimoto T; Yamauchi S; Yamanaka T; Miyamoto T; Kubota I; Watanabe M
Heart Vessels; 2019 Jan; 34(1):1-8. PubMed ID: 29936631
[TBL] [Abstract][Full Text] [Related]
2. Gender Differences in the Impact of Plasma Xanthine Oxidoreductase Activity on Coronary Artery Spasm.
Watanabe K; Watanabe T; Otaki Y; Murase T; Nakamura T; Kato S; Tamura H; Nishiyama S; Takahashi H; Arimoto T; Watanabe M
J Clin Med; 2021 Nov; 10(23):. PubMed ID: 34884248
[TBL] [Abstract][Full Text] [Related]
3. Relation of Plasma Xanthine Oxidoreductase Activity to Coronary Lipid Core Plaques Assessed by Near-Infrared Spectroscopy Intravascular Ultrasound in Patients With Stable Coronary Artery Disease.
Mori N; Saito Y; Saito K; Matsuoka T; Tateishi K; Kadohira T; Kitahara H; Fujimoto Y; Kobayashi Y
Am J Cardiol; 2020 Apr; 125(7):1006-1012. PubMed ID: 31955828
[TBL] [Abstract][Full Text] [Related]
4. Five-year major clinical outcomes according to severity of coronary artery spasm as assessed by intracoronary acetylcholine provocation test.
Kim YH; Her AY; Rha SW; Choi BG; Shim M; Choi SY; Byun JK; Li H; Kim W; Kang JH; Choi JY; Park EJ; Park SH; Lee S; Na JO; Choi CU; Lim HE; Kim EJ; Park CG; Seo HS; Oh DJ
Arch Cardiovasc Dis; 2018 Mar; 111(3):144-154. PubMed ID: 29030064
[TBL] [Abstract][Full Text] [Related]
5. Greater coronary lipid core plaque assessed by near-infrared spectroscopy intravascular ultrasound in patients with elevated xanthine oxidoreductase: a mechanistic insight.
Saito Y; Mori N; Murase T; Nakamura T; Akari S; Saito K; Matsuoka T; Tateishi K; Kadohira T; Kitahara H; Fujimoto Y; Kobayashi Y
Heart Vessels; 2021 May; 36(5):597-604. PubMed ID: 33219412
[TBL] [Abstract][Full Text] [Related]
6. The impact of myocardial bridge on coronary artery spasm and long-term clinical outcomes in patients without significant atherosclerotic stenosis.
Nam P; Choi BG; Choi SY; Byun JK; Mashaly A; Park Y; Jang WY; Kim W; Choi JY; Park EJ; Na JO; Choi CU; Lim HE; Kim EJ; Park CG; Seo HS; Oh DJ; Rha SW
Atherosclerosis; 2018 Mar; 270():8-12. PubMed ID: 29407892
[TBL] [Abstract][Full Text] [Related]
7. Association of the plasma xanthine oxidoreductase activity with the metabolic parameters and vascular complications in patients with type 2 diabetes.
Okuyama T; Shirakawa J; Nakamura T; Murase T; Miyashita D; Inoue R; Kyohara M; Togashi Y; Terauchi Y
Sci Rep; 2021 Feb; 11(1):3768. PubMed ID: 33580173
[TBL] [Abstract][Full Text] [Related]
8. Xanthine oxidoreductase activity is associated with serum uric acid and glycemic control in hemodialysis patients.
Nakatani A; Nakatani S; Ishimura E; Murase T; Nakamura T; Sakura M; Tateishi Y; Tsuda A; Kurajoh M; Mori K; Emoto M; Inaba M
Sci Rep; 2017 Nov; 7(1):15416. PubMed ID: 29133805
[TBL] [Abstract][Full Text] [Related]
9. Impact of alcohol drinking on acetylcholine-induced coronary artery spasm in Korean populations.
Sohn SM; Choi BG; Choi SY; Byun JK; Mashaly A; Park Y; Jang WY; Kim W; Choi JY; Park EJ; Na JO; Choi CU; Lim HE; Kim EJ; Park CG; Seo HS; Oh DJ; Rha SW
Atherosclerosis; 2018 Jan; 268():163-169. PubMed ID: 29227870
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of Patients with an Abnormally Decreased Plasma Xanthine Oxidoreductase Activity in Acute Heart Failure Who Visited the Emergency Department.
Shirakabe A; Okazaki H; Matsushita M; Shibata Y; Goda H; Shigihara S; Asano K; Tani K; Kiuchi K; Murase T; Nakamura T; Kobayashi N; Hata N; Asai K; Shimizu W
Cardiology; 2020; 145(8):473-480. PubMed ID: 32615578
[TBL] [Abstract][Full Text] [Related]
11. Xanthine oxidoreductase activity correlates with vascular endothelial dysfunction in patients with type 1 diabetes.
Washio K; Kusunoki Y; Tsunoda T; Osugi K; Ohigashi M; Murase T; Nakamura T; Matsuo T; Konishi K; Katsuno T; Namba M; Koyama H
Acta Diabetol; 2020 Jan; 57(1):31-39. PubMed ID: 31093763
[TBL] [Abstract][Full Text] [Related]
12. Association of plasma xanthine oxidoreductase activity with severity and clinical outcome in patients with chronic heart failure.
Otaki Y; Watanabe T; Kinoshita D; Yokoyama M; Takahashi T; Toshima T; Sugai T; Murase T; Nakamura T; Nishiyama S; Takahashi H; Arimoto T; Shishido T; Miyamoto T; Kubota I
Int J Cardiol; 2017 Feb; 228():151-157. PubMed ID: 27865177
[TBL] [Abstract][Full Text] [Related]
13. Annual change in plasma xanthine oxidoreductase activity is associated with changes in liver enzymes and body weight.
Furuhashi M; Koyama M; Matsumoto M; Murase T; Nakamura T; Higashiura Y; Tanaka M; Moniwa N; Ohnishi H; Saitoh S; Shimamoto K; Miura T
Endocr J; 2019 Sep; 66(9):777-786. PubMed ID: 31130575
[TBL] [Abstract][Full Text] [Related]
14. Sex Difference in Coronary Artery Spasm Tested by Intracoronary Acetylcholine Provocation Test in Patients with Nonobstructive Coronary Artery Disease.
Park JY; Choi SY; Rha SW; Choi BG; Noh YK; Kim YH
J Interv Cardiol; 2022; 2022():5289776. PubMed ID: 36131847
[TBL] [Abstract][Full Text] [Related]
15. Independent links between plasma xanthine oxidoreductase activity and levels of adipokines.
Furuhashi M; Matsumoto M; Murase T; Nakamura T; Higashiura Y; Koyama M; Tanaka M; Moniwa N; Ohnishi H; Saitoh S; Shimamoto K; Miura T
J Diabetes Investig; 2019 Jul; 10(4):1059-1067. PubMed ID: 30516339
[TBL] [Abstract][Full Text] [Related]
16. Five-year clinical outcomes in patients with significant coronary artery spasm: A propensity score-matched analysis.
Choi BG; Park SH; Rha SW; Park JY; Choi SY; Park Y; Xu S; Ngow HA; Ali J; Li H; Kim JB; Lee S; Na JO; Choi CU; Lim HE; Kim JW; Kim EJ; Park CG; Seo HS; Oh DJ
Int J Cardiol; 2015 Apr; 184():533-539. PubMed ID: 25767010
[TBL] [Abstract][Full Text] [Related]
17. Diabetes mellitus is not a risk factor for coronary artery spasm as assessed by an intracoronary acetylcholine provocation test: angiographic and clinical characteristics of 986 patients.
Li YJ; Hyun MH; Rha SW; Chen KY; Jin Z; Dang Q; Park CM; Lee JE; Park JY; Choi CU; Na JO; Lim HE; Kim JW; Kim EJ; Park CG; Seo HS; Oh DJ
J Invasive Cardiol; 2014 Jun; 26(6):234-9. PubMed ID: 24907077
[TBL] [Abstract][Full Text] [Related]
18. Induction of coronary artery spasm by two pharmacological agents: comparison between intracoronary injection of acetylcholine and ergonovine.
Sueda S; Kohno H; Fukuda H; Ochi N; Kawada H; Hayashi Y; Uraoka T
Coron Artery Dis; 2003 Sep; 14(6):451-7. PubMed ID: 12966266
[TBL] [Abstract][Full Text] [Related]
19. Independent association of plasma xanthine oxidoreductase activity with serum uric acid level based on stable isotope-labeled xanthine and liquid chromatography/triple quadrupole mass spectrometry: MedCity21 health examination registry.
Kurajoh M; Fukumoto S; Emoto M; Murase T; Nakamura T; Ishihara T; Go H; Yamamoto K; Nakatani S; Tsuda A; Yamada S; Morioka T; Mori K; Imanishi Y; Inaba M
Clin Chem Lab Med; 2020 Apr; 58(5):780-786. PubMed ID: 31085741
[TBL] [Abstract][Full Text] [Related]
20. The association of chronic air pollutants with coronary artery spasm, vasospastic angina, and endothelial dysfunction.
Choi BG; Lee J; Kim SW; Lee MW; Baek MJ; Ryu YG; Choi SY; Byun JK; Mashaly A; Park Y; Jang WY; Kim W; Choi JY; Park EJ; Na JO; Choi CU; Lim HE; Kim EJ; Park CG; Seo HS; Oh DJ; Rha SW
Coron Artery Dis; 2018 Jun; 29(4):336-343. PubMed ID: 29334505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
